Search Results for "A-200"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for A-200. Results 631 to 640 of 653 total matches.
Who Should Take Vitamin Supplements?
The Medical Letter on Drugs and Therapeutics • Dec 12, 2011 (Issue 1379)
-analysis of 30
trials involving 11,350 subjects showed that prophylactic
use of >200 mg/day of vitamin C ...
Many patients ask their healthcare providers whether
they should take vitamins. Since the last Medical Letter
article on this subject, more data have become available
on the benefits and risks of taking vitamins.
Daridorexant (Quviviq) for Insomnia
The Medical Letter on Drugs and Therapeutics • Jul 11, 2022 (Issue 1654)
106.0 -24.2* -24.3*
Placebo 71.8 -20.0 -19.9 108.1 -12.6 -14.0
* Statistically significant difference ...
The FDA has approved daridorexant (Quviviq –
Idorsia), an orexin receptor antagonist, for treatment
of sleep-onset and/or sleep-maintenance insomnia
in adults. Daridorexant is the third orexin receptor
antagonist to be approved for this indication;
suvorexant (Belsomra) and lemborexant (Dayvigo)
were approved earlier.
Suflave — A Low-Volume Colonoscopy Preparation
The Medical Letter on Drugs and Therapeutics • Sep 18, 2023 (Issue 1685)
24.90
23.70
39.10
Low-Volume PEG 3350-Based
MoviPrep (Salix)9
generic
200 g PEG 3350 powder10
240 ...
The FDA has approved Suflave (Sebela/Braintree), a
low-volume polyethylene glycol (PEG)- and sulfate-based
product for cleansing of the colon prior to
colonoscopy in adults. Other oral colonoscopy
preparations available in the US are listed in
Table 2. Suflave is marketed as tasting better than
other products.
Med Lett Drugs Ther. 2023 Sep 18;65(1685):148-51 doi:10.58347/tml.2023.1685b | Show Introduction Hide Introduction
Drugs for Percutaneous Coronary Interventions
The Medical Letter on Drugs and Therapeutics • Dec 06, 2004 (Issue 1197)
to ACT 250-300 sec
2
(50-70 post-PCI
units/kg IV if GP IIb/IIIa used,
titrate to ACT 200-250 sec ...
Percutaneous coronary intervention (PCI), such as balloon angioplasty or stent placement, predisposes to subsequent thrombosis. The current pharmacologic approach to prevention of this problem combines an anticoagulant with one or more antiplatelet drugs.
Vaccines for Travelers
The Medical Letter on Drugs and Therapeutics • Nov 19, 2018 (Issue 1560)
, and
those with asymptomatic HIV infection and moderate
immune suppression (CD4 counts 200-499 cells/mm3 ...
Persons planning to travel outside the US should be
up to date on routine vaccines and, depending on their
destination, duration of travel, and planned activities,
may also receive certain travel-specific vaccines.
Tickborne encephalitis and dengue vaccines, which
are not available in the US, are reviewed in a separate
article available online. Detailed advice for travel to
specific destinations is available from the Centers for
Disease Control and Prevention (CDC) at www.cdc.gov/travel/destinations/list. Recommendations for
administration of vaccines as part of routine...
Drugs for ADHD
The Medical Letter on Drugs and Therapeutics • Jan 27, 2020 (Issue 1590)
or bid32/40 mg See footnote 15 200.30
divided bid
Evekeo ODT 5, 10, 15, 20 mg ODT14 10 h31 5 mg qAM ...
Attention-deficit/hyperactivity disorder (ADHD) is a
chronic neurodevelopmental disorder that has been
diagnosed in up to 10% of school-age children in the
US and frequently persists into adulthood. A study in
a large Danish cohort found that ADHD was associated
with higher mortality rates in children, adolescents,
and adults, mainly due to accidents. Pharmacologic
treatment of ADHD in children has been reported to
decrease the risk of substance abuse in adolescents,
and use of ADHD medications in adults has been
associated with a reduced risk of serious traffic
accidents and...
Drugs for Treatment and Prevention of Venous Thromboembolism
The Medical Letter on Drugs and Therapeutics • Jul 25, 2022 (Issue 1655)
units SC q8-12h $651.00
Low-Molecular-Weight Heparins (LMWHs)
Dalteparin – Fragmin (Pfizer) 200 IU/kg ...
Anticoagulants are the drugs of choice for treatment
and prevention of deep venous thrombosis (DVT) and
pulmonary embolism (PE), collectively referred to as
venous thromboembolism (VTE). US guidelines for
treatment of VTE were updated in 2020 and 2021.
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
, 200 mg caps 200 mg PO once/day24 24.00
Antara27 (Lupin) 30, 90 mg caps 90 mg PO once/day 507.90 ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.
Varenicline (Chantix) for Tobacco Dependence
The Medical Letter on Drugs and Therapeutics • Aug 14, 2006 (Issue 1241)
,
hyperanxiety state, Stevens-Johnson
syndrome (rare)
sustained release – generic 100, 150 and 200 mg tabs ...
Varenicline tartrate (Chantix - Pfizer) is now available for oral treatment of tobacco dependence. Some other drugs for this indication are listed in this article.
Intravenous Immunoglobulin (IVIG)
The Medical Letter on Drugs and Therapeutics • Dec 04, 2006 (Issue 1249)
vials PID 200 mg/kg/mo
(Baxter) Kawasaki syndrome 2 g/kg over 10 hrs once or
400 mg/kg x 4d
2 ...
Intravenous immunoglobulin (IVIG) has 6 FDA approved indications and is prescribed off-label for many others. How many of these uses are justified is controversial.